Back to Search
Start Over
Long-term cognitive outcome of Alzheimer’s disease and dementia with Lewy bodies: dual disease is worse
- Source :
- Alzheimer’s Research & Therapy, Vol 9, Iss 1, Pp 1-9 (2017), Alzheimer's Research & Therapy, Alzheimer's Research and Therapy, Alzheimer's Research and Therapy, 2017, 9 (1), pp.47. ⟨10.1186/s13195-017-0272-8⟩, Alzheimer's Research and Therapy, BioMed Central, 2017, 9 (1), pp.47. ⟨10.1186/s13195-017-0272-8⟩
- Publication Year :
- 2017
- Publisher :
- BMC, 2017.
-
Abstract
- Background Longitudinal studies of dementia with Lewy bodies (DLB) are rare. Clinically, DLB is usually considered to worsen into Alzheimer’s disease (AD). The aim of our study was to compare the rate of the cognitive decline in DLB, AD, and the association of the two diseases (AD + DLB). Methods Using the Regional Network for Diagnostic Aid and Management of Patients with Cognitive Impairment database, which includes all the patients seen at all memory clinics (medical consultation and day hospitals) in four French regions, and beta regression, we compared the longitudinal the Mini-Mental State Examination scores of 1159 patients with AD (n = 1000), DLB (n = 131) and AD + DLB (association of the two) (n = 28) during follow-up of at least 4 years. Results The mean follow-up of the patients was 5.88 years. Using beta regression without propensity scores, the comparison of the decline of patients with AD and patients with DLB did not show a significant difference, but the decline of patients with AD + DLB was worse than that of either patients with DLB (P = 0.006) or patients with AD (P
- Subjects :
- Male
Neurology
Dementia with Lewy bodies
Disease
Comorbidity
lcsh:RC346-429
0302 clinical medicine
Risk Factors
Prevalence
030212 general & internal medicine
Longitudinal Studies
Cognitive decline
ComputingMilieux_MISCELLANEOUS
Outcome
[SDV.MHEP.GEG] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontology
[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontology
Cognition
Prognosis
3. Good health
Causality
Female
France
Alzheimer’s disease
medicine.medical_specialty
Alzheimer’s dementia
Cognitive Neuroscience
Lewy body disease
behavioral disciplines and activities
MMSE
lcsh:RC321-571
03 medical and health sciences
Alzheimer Disease
Internal medicine
mental disorders
medicine
Humans
Cognitive Dysfunction
Psychiatry
lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry
lcsh:Neurology. Diseases of the nervous system
Aged
business.industry
Research
Significant difference
medicine.disease
nervous system diseases
nervous system
[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie
Propensity score matching
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Neurology (clinical)
business
030217 neurology & neurosurgery
Geriatric psychiatry
Subjects
Details
- Language :
- English
- ISSN :
- 17589193
- Volume :
- 9
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Alzheimer’s Research & Therapy
- Accession number :
- edsair.doi.dedup.....bfbb31f6d9db936a64f003d86964ccc4
- Full Text :
- https://doi.org/10.1186/s13195-017-0272-8